Skip to content
Loading...

New EASL Clinical Practice Guidelines on Liver Transplantation

  • Chiara Hartmann
  • news

EASL has released its updated Clinical Practice Guidelines on Liver Transplantation (LT). The guidelines represent a significant overhaul, reflecting major advancements in the field since the last update in 2016. The field of liver transplantation (LT) has advanced significantly in…

Read more

Interview with Sarina Shabso, 2024 Daniel Alagille Awardee

  • Chiara Hartmann
  • news

The recipient of the 2024 Daniel Alagille Award, Sarina Shabso, discusses her inspiring journey into the field of hepatology. Shabso's path, from her early focus on skin regeneration to her groundbreaking research on genetic cholestatic diseases, showcases her dedication and…

Read more

Interview with Scott Waddell, 2023 Daniel Alagille Awardee

  • Chiara Hartmann
  • news

In an insightful conversation with EASL, Scott Waddell, the recipient of the 2023 Daniel Alagille Award, shares his journey into the field of hepatology. From his initial focus on cholangiocarcinoma to his pioneering work on polycystic liver disease, Waddell's dedication…

Read more

Join the EASL Educational Committee!

  • Adonia DHANJAL
  • news

The EASL Educational Committee provides scientific expertise and support to the EASL Governing Board and EASL office, in the development and monitoring of a high-quality portfolio of educational offerings in support of EASL’s educational strategy and commitment to remaining a…

Read more

European Medicines Association (EMA) statement on Obeticholic acid for the treatment of primary biliary cholangitis (PBC) European Association for the Study of the Liver (EASL) perspective

  • Chiara Hartmann
  • news

The EMA human medicines committee (CHMP) has recently issued a statement on Obeticholic acid for the treatment of Primary Biliary Cholangitis (PBC). The CHMP recommended to the European Commission that the market authorisation for Obeticholic acid in the European Union…

Read more
Back To Top